I don't see this as a misprint. It's an indication of where the stock price will be if Positron doesn't sell something (anything) soon. The Board's moronic belief that a reverse split would make Positron's stock and business suddenly appear more viable to large investors is laughable. Only significant, predictable, profitable, growing sales of radiopharmaceuticals will generate interest in this stock.